MedPath

Study of Histological Samples From Patients With Hereditary Haemorrhagic Telangiectasia

Completed
Conditions
Telangiectasia, Hereditary Hemorrhagic
Registration Number
NCT00733655
Lead Sponsor
Imperial College London
Brief Summary

In this study the investigators will obtain histological samples from people with hereditary haemorrhagic telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome).

Detailed Description

HHT is an inherited condition that leads to the development of dilated and fragile blood vessels. We propose to obtain small skin samples from patients with HHT in order to analyze the samples using histological methods, and study the properties of vascular endothelial cells derived from patients. We hypothesize that these cells will show differences when compared to normal endothelial cells, which may be confirmed in single time point analyses in histological samples. We anticipate that that these findings may help to explain aspects of the HHT disease phenotype.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • Patients with Hereditary Haemorrhagic Telangiectasia
Exclusion Criteria
  • Unable to provide informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Imperial College Hammersmith Campus

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath